Concepts (320)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tissue Engineering | 56 | 2023 | 608 | 7.830 |
Why?
|
| Tissue Scaffolds | 45 | 2023 | 386 | 7.510 |
Why?
|
| Regeneration | 9 | 2023 | 167 | 2.620 |
Why?
|
| Muscle, Skeletal | 10 | 2020 | 494 | 2.240 |
Why?
|
| Collagen | 15 | 2020 | 217 | 2.230 |
Why?
|
| Polyesters | 16 | 2019 | 72 | 2.190 |
Why?
|
| Extracellular Matrix | 12 | 2023 | 226 | 2.070 |
Why?
|
| Biocompatible Materials | 19 | 2023 | 210 | 1.920 |
Why?
|
| Animals | 61 | 2023 | 7297 | 1.790 |
Why?
|
| Hydrogels | 12 | 2020 | 103 | 1.770 |
Why?
|
| Bioprosthesis | 4 | 2023 | 55 | 1.730 |
Why?
|
| Blood Vessel Prosthesis | 9 | 2023 | 78 | 1.700 |
Why?
|
| Stem Cells | 10 | 2020 | 292 | 1.670 |
Why?
|
| Myocytes, Smooth Muscle | 6 | 2017 | 74 | 1.580 |
Why?
|
| Ear Cartilage | 4 | 2021 | 11 | 1.530 |
Why?
|
| Gelatin | 6 | 2019 | 27 | 1.490 |
Why?
|
| Myoblasts, Skeletal | 2 | 2020 | 16 | 1.440 |
Why?
|
| Guided Tissue Regeneration | 6 | 2020 | 36 | 1.370 |
Why?
|
| Materials Testing | 10 | 2018 | 84 | 1.240 |
Why?
|
| Alginates | 3 | 2023 | 49 | 1.140 |
Why?
|
| Cell Differentiation | 12 | 2020 | 436 | 1.080 |
Why?
|
| Microscopy, Electron, Scanning | 18 | 2020 | 92 | 1.060 |
Why?
|
| Amniotic Fluid | 7 | 2019 | 84 | 1.020 |
Why?
|
| Polyglactin 910 | 2 | 2019 | 4 | 1.010 |
Why?
|
| Cell Proliferation | 16 | 2020 | 573 | 1.010 |
Why?
|
| Cells, Cultured | 18 | 2019 | 799 | 0.970 |
Why?
|
| Lactic Acid | 7 | 2014 | 52 | 0.930 |
Why?
|
| Drug Delivery Systems | 3 | 2013 | 92 | 0.910 |
Why?
|
| Wound Healing | 6 | 2023 | 182 | 0.910 |
Why?
|
| Polymers | 5 | 2016 | 59 | 0.870 |
Why?
|
| Rats | 14 | 2020 | 1604 | 0.810 |
Why?
|
| Reperfusion Injury | 2 | 2020 | 43 | 0.790 |
Why?
|
| Swine | 11 | 2023 | 201 | 0.770 |
Why?
|
| Cell Survival | 11 | 2020 | 272 | 0.760 |
Why?
|
| Blood Vessels | 3 | 2010 | 47 | 0.750 |
Why?
|
| Muscular Diseases | 1 | 2020 | 19 | 0.730 |
Why?
|
| Ink | 2 | 2019 | 11 | 0.730 |
Why?
|
| Nanofibers | 1 | 2019 | 4 | 0.730 |
Why?
|
| Kidney | 4 | 2022 | 485 | 0.710 |
Why?
|
| Humans | 42 | 2023 | 29093 | 0.680 |
Why?
|
| Skin Transplantation | 2 | 2023 | 50 | 0.660 |
Why?
|
| Mice | 22 | 2023 | 2368 | 0.640 |
Why?
|
| Kidney Glomerulus | 1 | 2018 | 30 | 0.630 |
Why?
|
| Stem Cell Transplantation | 3 | 2019 | 203 | 0.620 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2017 | 71 | 0.620 |
Why?
|
| Neurons | 2 | 2020 | 394 | 0.610 |
Why?
|
| Bone Regeneration | 4 | 2020 | 28 | 0.600 |
Why?
|
| Cell Adhesion | 12 | 2012 | 103 | 0.600 |
Why?
|
| Regenerative Medicine | 3 | 2019 | 187 | 0.590 |
Why?
|
| Burns | 1 | 2017 | 97 | 0.560 |
Why?
|
| Cardiovascular Diseases | 1 | 2023 | 1013 | 0.550 |
Why?
|
| Osteogenesis | 7 | 2020 | 75 | 0.550 |
Why?
|
| Tensile Strength | 9 | 2018 | 52 | 0.540 |
Why?
|
| Osteoblasts | 2 | 2006 | 46 | 0.520 |
Why?
|
| RNA | 1 | 2015 | 88 | 0.520 |
Why?
|
| Kidney Diseases | 1 | 2018 | 239 | 0.520 |
Why?
|
| Heparin | 2 | 2012 | 75 | 0.520 |
Why?
|
| Cells, Immobilized | 2 | 2014 | 23 | 0.520 |
Why?
|
| Rabbits | 7 | 2019 | 185 | 0.510 |
Why?
|
| Prostheses and Implants | 2 | 2014 | 41 | 0.500 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2014 | 8 | 0.500 |
Why?
|
| Muscle Fibers, Skeletal | 6 | 2019 | 104 | 0.500 |
Why?
|
| Chondrocytes | 5 | 2018 | 71 | 0.490 |
Why?
|
| Cell Culture Techniques | 7 | 2016 | 165 | 0.470 |
Why?
|
| Fibrin | 1 | 2013 | 6 | 0.460 |
Why?
|
| Rheology | 5 | 2019 | 28 | 0.450 |
Why?
|
| Trachea | 3 | 2019 | 55 | 0.450 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2012 | 9 | 0.440 |
Why?
|
| Muramidase | 1 | 2012 | 8 | 0.430 |
Why?
|
| Chemokine CXCL12 | 1 | 2011 | 25 | 0.410 |
Why?
|
| Proteins | 1 | 2013 | 140 | 0.410 |
Why?
|
| Substance P | 1 | 2011 | 22 | 0.410 |
Why?
|
| Nanostructures | 2 | 2008 | 16 | 0.400 |
Why?
|
| Muscle Development | 3 | 2019 | 45 | 0.390 |
Why?
|
| Endothelial Cells | 5 | 2014 | 179 | 0.370 |
Why?
|
| Skin | 2 | 2023 | 203 | 0.360 |
Why?
|
| Mesenchymal Stem Cells | 4 | 2019 | 161 | 0.360 |
Why?
|
| Absorbable Implants | 2 | 2013 | 24 | 0.350 |
Why?
|
| Polyglycolic Acid | 5 | 2013 | 32 | 0.350 |
Why?
|
| Neurites | 2 | 2013 | 8 | 0.340 |
Why?
|
| Transplantation | 1 | 2008 | 12 | 0.330 |
Why?
|
| Cattle | 6 | 2015 | 100 | 0.330 |
Why?
|
| Porosity | 6 | 2018 | 36 | 0.320 |
Why?
|
| Feasibility Studies | 2 | 2020 | 263 | 0.320 |
Why?
|
| Glycolates | 2 | 2005 | 5 | 0.310 |
Why?
|
| Intestine, Small | 2 | 2006 | 34 | 0.310 |
Why?
|
| Cell Line | 9 | 2019 | 449 | 0.300 |
Why?
|
| Intestinal Mucosa | 2 | 2006 | 64 | 0.300 |
Why?
|
| Polycarboxylate Cement | 2 | 2004 | 2 | 0.300 |
Why?
|
| Surface Properties | 6 | 2010 | 32 | 0.300 |
Why?
|
| Ear Auricle | 2 | 2018 | 5 | 0.290 |
Why?
|
| Disease Models, Animal | 3 | 2020 | 980 | 0.290 |
Why?
|
| Neuromuscular Junction | 2 | 2020 | 67 | 0.290 |
Why?
|
| Antigens, CD | 2 | 2018 | 100 | 0.290 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2020 | 268 | 0.280 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2019 | 100 | 0.280 |
Why?
|
| Time Factors | 4 | 2020 | 2001 | 0.250 |
Why?
|
| Bone Substitutes | 1 | 2004 | 8 | 0.250 |
Why?
|
| Cross-Linking Reagents | 3 | 2014 | 16 | 0.250 |
Why?
|
| Bone and Bones | 2 | 2004 | 87 | 0.240 |
Why?
|
| Immunohistochemistry | 2 | 2017 | 519 | 0.240 |
Why?
|
| Polyethylene | 1 | 2003 | 6 | 0.230 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2023 | 40 | 0.230 |
Why?
|
| Male | 13 | 2020 | 17807 | 0.230 |
Why?
|
| Oxygen | 4 | 2022 | 139 | 0.230 |
Why?
|
| Islets of Langerhans | 1 | 2023 | 74 | 0.230 |
Why?
|
| Sheep | 4 | 2017 | 221 | 0.220 |
Why?
|
| Collagen Type I | 3 | 2013 | 39 | 0.220 |
Why?
|
| Nerve Regeneration | 2 | 2013 | 40 | 0.220 |
Why?
|
| Chlorates | 1 | 2002 | 1 | 0.210 |
Why?
|
| Tendons | 2 | 2013 | 57 | 0.210 |
Why?
|
| Viscosity | 2 | 2018 | 21 | 0.200 |
Why?
|
| Elasticity | 2 | 2018 | 34 | 0.200 |
Why?
|
| Kinetics | 3 | 2022 | 205 | 0.200 |
Why?
|
| Pregnancy | 3 | 2020 | 815 | 0.200 |
Why?
|
| Rats, Inbred Lew | 3 | 2015 | 116 | 0.190 |
Why?
|
| Delayed-Action Preparations | 2 | 2012 | 35 | 0.190 |
Why?
|
| Biomimetic Materials | 1 | 2020 | 14 | 0.180 |
Why?
|
| Mandibular Prosthesis | 1 | 2019 | 2 | 0.180 |
Why?
|
| Calcium Phosphates | 1 | 2019 | 9 | 0.170 |
Why?
|
| Fibroblasts | 4 | 2020 | 103 | 0.170 |
Why?
|
| Methacrylates | 1 | 2019 | 3 | 0.170 |
Why?
|
| Kidney Function Tests | 1 | 2019 | 102 | 0.170 |
Why?
|
| Thrombin | 2 | 2010 | 15 | 0.170 |
Why?
|
| Ultraviolet Rays | 1 | 2019 | 46 | 0.170 |
Why?
|
| Algorithms | 1 | 2022 | 462 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 2 | 2018 | 711 | 0.170 |
Why?
|
| Nerve Net | 1 | 2020 | 115 | 0.170 |
Why?
|
| Graft Survival | 2 | 2017 | 228 | 0.160 |
Why?
|
| Fibroins | 1 | 2018 | 5 | 0.160 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2019 | 80 | 0.160 |
Why?
|
| Reconstructive Surgical Procedures | 2 | 2018 | 190 | 0.160 |
Why?
|
| Myoblasts | 2 | 2015 | 38 | 0.160 |
Why?
|
| Myocardial Contraction | 1 | 2018 | 55 | 0.160 |
Why?
|
| Tissue Expansion Devices | 1 | 2017 | 10 | 0.150 |
Why?
|
| Cytokines | 1 | 2019 | 243 | 0.150 |
Why?
|
| Myocytes, Cardiac | 1 | 2018 | 87 | 0.150 |
Why?
|
| Cicatrix | 1 | 2017 | 36 | 0.150 |
Why?
|
| Bioartificial Organs | 2 | 2015 | 25 | 0.150 |
Why?
|
| Polyurethanes | 1 | 2016 | 4 | 0.150 |
Why?
|
| Myocardium | 1 | 2018 | 170 | 0.150 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2017 | 68 | 0.150 |
Why?
|
| NIH 3T3 Cells | 4 | 2011 | 43 | 0.150 |
Why?
|
| Ovarian Follicle | 1 | 2016 | 23 | 0.150 |
Why?
|
| Rats, Nude | 4 | 2020 | 38 | 0.150 |
Why?
|
| Spectroscopy, Near-Infrared | 2 | 2013 | 10 | 0.140 |
Why?
|
| Mice, Nude | 5 | 2020 | 276 | 0.140 |
Why?
|
| Sus scrofa | 2 | 2015 | 44 | 0.140 |
Why?
|
| Myostatin | 1 | 2015 | 3 | 0.140 |
Why?
|
| Myogenic Regulatory Factors | 1 | 2015 | 8 | 0.140 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2018 | 747 | 0.140 |
Why?
|
| Pulmonary Valve | 1 | 2015 | 10 | 0.140 |
Why?
|
| RNA Interference | 1 | 2015 | 76 | 0.130 |
Why?
|
| Cell Movement | 3 | 2019 | 161 | 0.130 |
Why?
|
| Glycoproteins | 1 | 2015 | 34 | 0.130 |
Why?
|
| Muscular Atrophy | 1 | 2015 | 67 | 0.130 |
Why?
|
| RNA, Small Interfering | 1 | 2015 | 109 | 0.130 |
Why?
|
| Heart Valve Prosthesis | 1 | 2015 | 53 | 0.130 |
Why?
|
| Peptides | 1 | 2015 | 118 | 0.130 |
Why?
|
| Adipogenesis | 2 | 2020 | 26 | 0.130 |
Why?
|
| PAX7 Transcription Factor | 1 | 2014 | 8 | 0.130 |
Why?
|
| Cell Division | 3 | 2004 | 97 | 0.120 |
Why?
|
| Cytoskeleton | 2 | 2013 | 16 | 0.120 |
Why?
|
| Gene Expression | 1 | 2015 | 332 | 0.120 |
Why?
|
| Down-Regulation | 1 | 2014 | 143 | 0.120 |
Why?
|
| Antibodies, Monoclonal | 1 | 2015 | 196 | 0.120 |
Why?
|
| Bioreactors | 2 | 2015 | 59 | 0.120 |
Why?
|
| Elastic Modulus | 3 | 2019 | 24 | 0.120 |
Why?
|
| MicroRNAs | 1 | 2015 | 173 | 0.120 |
Why?
|
| Fiber Optic Technology | 1 | 2013 | 14 | 0.120 |
Why?
|
| Poloxamer | 1 | 2013 | 4 | 0.110 |
Why?
|
| Serum Albumin, Bovine | 1 | 2013 | 9 | 0.110 |
Why?
|
| Carbocyanines | 1 | 2013 | 3 | 0.110 |
Why?
|
| Myoglobin | 1 | 2013 | 11 | 0.110 |
Why?
|
| Transplants | 1 | 2013 | 22 | 0.110 |
Why?
|
| Receptors, Cholinergic | 1 | 2013 | 21 | 0.110 |
Why?
|
| Soft Tissue Injuries | 1 | 2013 | 27 | 0.110 |
Why?
|
| Injections | 1 | 2013 | 61 | 0.110 |
Why?
|
| Embryonic Stem Cells | 1 | 2013 | 30 | 0.110 |
Why?
|
| Fluorescent Dyes | 1 | 2013 | 45 | 0.110 |
Why?
|
| Enzymes, Immobilized | 1 | 2012 | 3 | 0.110 |
Why?
|
| Pilot Projects | 3 | 2019 | 469 | 0.110 |
Why?
|
| Chondrogenesis | 1 | 2012 | 18 | 0.110 |
Why?
|
| 3T3 Cells | 3 | 2002 | 13 | 0.110 |
Why?
|
| Culture Media | 1 | 2012 | 39 | 0.110 |
Why?
|
| Endothelium, Vascular | 1 | 2013 | 145 | 0.110 |
Why?
|
| Amines | 1 | 2012 | 22 | 0.110 |
Why?
|
| Cell Lineage | 1 | 2012 | 67 | 0.110 |
Why?
|
| Mechanical Phenomena | 1 | 2012 | 27 | 0.110 |
Why?
|
| Peripheral Nerves | 1 | 2012 | 58 | 0.100 |
Why?
|
| Heart Valves | 1 | 2011 | 15 | 0.100 |
Why?
|
| Neurosurgical Procedures | 1 | 2012 | 98 | 0.100 |
Why?
|
| Recovery of Function | 1 | 2013 | 190 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2011 | 24 | 0.100 |
Why?
|
| Mice, Inbred Strains | 1 | 2011 | 43 | 0.100 |
Why?
|
| Neurotransmitter Agents | 1 | 2011 | 26 | 0.100 |
Why?
|
| Chemotaxis | 1 | 2011 | 23 | 0.100 |
Why?
|
| Water | 2 | 2004 | 50 | 0.100 |
Why?
|
| Urinary Bladder | 2 | 2013 | 164 | 0.100 |
Why?
|
| Flow Cytometry | 1 | 2011 | 171 | 0.100 |
Why?
|
| Analysis of Variance | 1 | 2012 | 454 | 0.100 |
Why?
|
| Female | 6 | 2020 | 18164 | 0.100 |
Why?
|
| Fibrinogen | 1 | 2010 | 42 | 0.100 |
Why?
|
| Neovascularization, Physiologic | 1 | 2011 | 106 | 0.100 |
Why?
|
| Hardness | 2 | 2015 | 5 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2013 | 1218 | 0.100 |
Why?
|
| Electrochemical Techniques | 1 | 2010 | 22 | 0.090 |
Why?
|
| Foreskin | 1 | 2009 | 8 | 0.090 |
Why?
|
| Tissue Culture Techniques | 1 | 2009 | 40 | 0.090 |
Why?
|
| Elastin | 2 | 2006 | 14 | 0.090 |
Why?
|
| Cell Count | 1 | 2008 | 50 | 0.080 |
Why?
|
| Compressive Strength | 2 | 2019 | 20 | 0.080 |
Why?
|
| Hemostatics | 1 | 2006 | 12 | 0.070 |
Why?
|
| Embryo, Mammalian | 1 | 2006 | 30 | 0.070 |
Why?
|
| Anterior Cruciate Ligament | 1 | 2006 | 41 | 0.070 |
Why?
|
| Prosthesis Implantation | 2 | 2016 | 35 | 0.070 |
Why?
|
| Cell Size | 1 | 2004 | 32 | 0.060 |
Why?
|
| Absorption | 1 | 2004 | 15 | 0.060 |
Why?
|
| Phenotype | 2 | 2016 | 629 | 0.060 |
Why?
|
| Epidermis | 1 | 2023 | 23 | 0.060 |
Why?
|
| Cell Separation | 2 | 2015 | 86 | 0.060 |
Why?
|
| Microscopy, Fluorescence | 2 | 2014 | 81 | 0.060 |
Why?
|
| Wettability | 1 | 2003 | 2 | 0.060 |
Why?
|
| PC12 Cells | 1 | 2003 | 7 | 0.060 |
Why?
|
| Electrodes | 1 | 2003 | 16 | 0.060 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2013 | 40 | 0.060 |
Why?
|
| Pancreas | 1 | 2023 | 79 | 0.060 |
Why?
|
| Biomedical Engineering | 2 | 2013 | 23 | 0.050 |
Why?
|
| Starch | 2 | 2012 | 7 | 0.050 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 2 | 2012 | 7 | 0.050 |
Why?
|
| Carbonates | 1 | 2022 | 3 | 0.050 |
Why?
|
| Catalase | 1 | 2022 | 16 | 0.050 |
Why?
|
| Alkaline Phosphatase | 2 | 2012 | 36 | 0.050 |
Why?
|
| Peroxides | 1 | 2022 | 31 | 0.050 |
Why?
|
| Biodegradation, Environmental | 1 | 2002 | 4 | 0.050 |
Why?
|
| Models, Chemical | 1 | 2002 | 30 | 0.050 |
Why?
|
| Insulin | 1 | 2023 | 346 | 0.050 |
Why?
|
| Calcium | 2 | 2013 | 296 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2012 | 82 | 0.050 |
Why?
|
| Keratinocytes | 1 | 2020 | 26 | 0.050 |
Why?
|
| Fibrosis | 1 | 2020 | 102 | 0.040 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2019 | 20 | 0.040 |
Why?
|
| Podocytes | 1 | 2019 | 20 | 0.040 |
Why?
|
| Cues | 1 | 2019 | 67 | 0.040 |
Why?
|
| Prosthesis Fitting | 1 | 2019 | 3 | 0.040 |
Why?
|
| Osteocytes | 1 | 2019 | 4 | 0.040 |
Why?
|
| Ischemia | 1 | 2020 | 92 | 0.040 |
Why?
|
| Membranes, Artificial | 1 | 1999 | 7 | 0.040 |
Why?
|
| X-Ray Microtomography | 1 | 2019 | 40 | 0.040 |
Why?
|
| Prosthesis Design | 1 | 2019 | 87 | 0.040 |
Why?
|
| Polyethylenes | 1 | 2018 | 2 | 0.040 |
Why?
|
| Esthetics | 1 | 2018 | 11 | 0.040 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2019 | 75 | 0.040 |
Why?
|
| Light | 1 | 2018 | 25 | 0.040 |
Why?
|
| Meiosis | 1 | 2016 | 10 | 0.040 |
Why?
|
| Oocytes | 1 | 2016 | 21 | 0.040 |
Why?
|
| Rats, Inbred F344 | 1 | 2016 | 125 | 0.040 |
Why?
|
| Bronchoscopy | 1 | 2016 | 56 | 0.040 |
Why?
|
| Progesterone | 1 | 2016 | 80 | 0.040 |
Why?
|
| Estradiol | 1 | 2016 | 118 | 0.030 |
Why?
|
| Mandible | 1 | 2016 | 38 | 0.030 |
Why?
|
| Cell-Free System | 1 | 2015 | 15 | 0.030 |
Why?
|
| Tissue Survival | 1 | 2015 | 12 | 0.030 |
Why?
|
| Solutions | 1 | 2015 | 26 | 0.030 |
Why?
|
| Urea | 1 | 2015 | 33 | 0.030 |
Why?
|
| Albumins | 1 | 2015 | 38 | 0.030 |
Why?
|
| Spheroids, Cellular | 1 | 2015 | 28 | 0.030 |
Why?
|
| Equipment Failure Analysis | 1 | 2015 | 42 | 0.030 |
Why?
|
| Polyethylene Glycols | 1 | 2015 | 65 | 0.030 |
Why?
|
| Stress, Mechanical | 1 | 2015 | 90 | 0.030 |
Why?
|
| Perfusion | 1 | 2015 | 64 | 0.030 |
Why?
|
| Equipment Design | 1 | 2015 | 167 | 0.030 |
Why?
|
| Intracellular Space | 1 | 2014 | 16 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2014 | 51 | 0.030 |
Why?
|
| Adenosine | 1 | 2014 | 41 | 0.030 |
Why?
|
| Tenascin | 1 | 2013 | 3 | 0.030 |
Why?
|
| Collagen Type III | 1 | 2013 | 13 | 0.030 |
Why?
|
| Protein Transport | 1 | 2013 | 74 | 0.030 |
Why?
|
| Tendon Injuries | 1 | 2013 | 36 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2013 | 39 | 0.030 |
Why?
|
| Sulfonic Acids | 1 | 2013 | 2 | 0.030 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2013 | 7 | 0.030 |
Why?
|
| Bis-Trimethylammonium Compounds | 1 | 2013 | 1 | 0.030 |
Why?
|
| Agrin | 1 | 2013 | 5 | 0.030 |
Why?
|
| Collagenases | 1 | 2013 | 9 | 0.030 |
Why?
|
| Infrared Rays | 1 | 2013 | 18 | 0.030 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2013 | 27 | 0.030 |
Why?
|
| Chick Embryo | 1 | 2013 | 73 | 0.030 |
Why?
|
| Mucous Membrane | 1 | 2013 | 20 | 0.030 |
Why?
|
| Muscle Denervation | 1 | 2013 | 28 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2013 | 55 | 0.030 |
Why?
|
| Apoptosis | 1 | 2015 | 337 | 0.030 |
Why?
|
| Acetylcholine | 1 | 2013 | 47 | 0.030 |
Why?
|
| Peroneal Nerve | 1 | 2012 | 14 | 0.030 |
Why?
|
| Calcification, Physiologic | 1 | 2012 | 9 | 0.030 |
Why?
|
| Axons | 1 | 2012 | 24 | 0.030 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2012 | 4 | 0.030 |
Why?
|
| Sciatic Nerve | 1 | 2012 | 35 | 0.030 |
Why?
|
| Spectrometry, X-Ray Emission | 1 | 2012 | 3 | 0.030 |
Why?
|
| Anthraquinones | 1 | 2012 | 5 | 0.030 |
Why?
|
| Aggrecans | 1 | 2012 | 4 | 0.030 |
Why?
|
| Sepharose | 1 | 2012 | 5 | 0.030 |
Why?
|
| Collagen Type II | 1 | 2012 | 8 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2012 | 77 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2013 | 130 | 0.030 |
Why?
|
| Staining and Labeling | 1 | 2012 | 56 | 0.030 |
Why?
|
| Biological Transport | 1 | 2011 | 62 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 481 | 0.020 |
Why?
|
| Octoxynol | 1 | 2009 | 7 | 0.020 |
Why?
|
| Platelet Adhesiveness | 1 | 2008 | 13 | 0.020 |
Why?
|
| Stifle | 1 | 2006 | 4 | 0.020 |
Why?
|
| Biological Dressings | 1 | 2006 | 1 | 0.020 |
Why?
|
| Occlusive Dressings | 1 | 2006 | 10 | 0.020 |
Why?
|
| Bandages | 1 | 2006 | 33 | 0.020 |
Why?
|
| Shear Strength | 1 | 2005 | 8 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 641 | 0.020 |
Why?
|
| Carbon | 1 | 1999 | 10 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 1999 | 250 | 0.010 |
Why?
|
| Aged | 1 | 2008 | 9487 | 0.010 |
Why?
|
| Middle Aged | 1 | 2008 | 10829 | 0.010 |
Why?
|